The immune subtypes and landscape of squamous cell carcinoma B Li, Y Cui, DK Nambiar, JB Sunwoo, R Li Clinical Cancer Research 25 (12), 3528-3537, 2019 | 156 | 2019 |
Usnic acid inhibits growth and induces cell cycle arrest and apoptosis in human lung carcinoma A549 cells N Singh, D Nambiar, RK Kale, RP Singh Nutrition and cancer 65 (sup1), 36-43, 2013 | 124 | 2013 |
Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy D Nambiar, P Rajamani, RP Singh Mutation Research/Reviews in Mutation Research 728 (3), 139-157, 2011 | 124 | 2011 |
Galectin-1–driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance DK Nambiar, T Aguilera, H Cao, S Kwok, C Kong, J Bloomstein, Z Wang, ... The Journal of clinical investigation 129 (12), 5553-5567, 2019 | 116 | 2019 |
Hypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation IR Schlaepfer, DK Nambiar, A Ramteke, R Kumar, D Dhar, C Agarwal, ... Oncotarget 6 (26), 22836, 2015 | 101 | 2015 |
Fisetin inhibits various attributes of angiogenesis in vitro and in vivo —implications for angioprevention TA Bhat, D Nambiar, A Pal, R Agarwal, RP Singh Carcinogenesis 33 (2), 385-393, 2012 | 98 | 2012 |
Chemical space mimicry for drug discovery W Yuan, D Jiang, DK Nambiar, LP Liew, MP Hay, J Bloomstein, P Lu, ... Journal of chemical information and modeling 57 (4), 875-882, 2017 | 90 | 2017 |
Acacetin Inhibits In Vitro and In Vivo Angiogenesis and Downregulates Stat Signaling and VEGF Expression TA Bhat, D Nambiar, D Tailor, A Pal, R Agarwal, RP Singh Cancer Prevention Research 6 (10), 1128-1139, 2013 | 76 | 2013 |
In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells D Nambiar, V Prajapati, R Agarwal, RP Singh Cancer letters 334 (1), 109-117, 2013 | 69 | 2013 |
Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element … DK Nambiar, G Deep, RP Singh, C Agarwal, R Agarwal Oncotarget 5 (20), 10017, 2014 | 61 | 2014 |
Silibinin inhibits hypoxia‐induced HIF‐1α‐mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: in vitro evidence and in vivo functional imaging and … G Deep, R Kumar, DK Nambiar, AK Jain, AM Ramteke, NJ Serkova, ... Molecular carcinogenesis 56 (3), 833-848, 2017 | 60 | 2017 |
Silibinin attenuates ionizing radiation-induced pro-angiogenic response and EMT in prostate cancer cells DK Nambiar, P Rajamani, RP Singh Biochemical and biophysical research communications 456 (1), 262-268, 2015 | 49 | 2015 |
Silibinin preferentially radiosensitizes prostate cancer by inhibiting DNA repair signaling DK Nambiar, P Rajamani, G Deep, AK Jain, R Agarwal, RP Singh Molecular cancer therapeutics 14 (12), 2722-2734, 2015 | 44 | 2015 |
The prevalence of alcohol and other drugs in fatal road crashes in Victoria, Australia J Schumann, M Perkins, P Dietze, D Nambiar, B Mitra, D Gerostamoulos, ... Accident Analysis & Prevention 153, 105905, 2021 | 32 | 2021 |
Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer D Tailor, A Resendez, FJ Garcia-Marques, M Pandrala, CC Going, ... Cell Chemical Biology 28 (8), 1206-1220. e6, 2021 | 30 | 2021 |
Aldehyde dehydrogenase 3A1 activation prevents radiation-induced xerostomia by protecting salivary stem cells from toxic aldehydes JP Saiki, H Cao, LD Van Wassenhove, V Viswanathan, J Bloomstein, ... Proceedings of the National Academy of Sciences 115 (24), 6279-6284, 2018 | 25 | 2018 |
Advances in prostate cancer chemoprevention: a translational perspective D Nambiar, RP Singh Nutrition and cancer 65 (sup1), 12-25, 2013 | 25 | 2013 |
NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells L Guan, DK Nambiar, H Cao, V Viswanathan, S Kwok, AB Hui, Y Hou, ... Cancer research 83 (6), 861-874, 2023 | 18 | 2023 |
Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancer D Tailor, CC Going, A Resendez, V Kumar, DK Nambiar, Y Li, A Dheeraj, ... British Journal of Cancer 124 (3), 604-615, 2021 | 16 | 2021 |
Targeting DNA repair for cancer treatment: Lessons from PARP inhibitor trials DK Nambiar, D Mishra, RP Singh Oncology research 31 (4), 405, 2023 | 10 | 2023 |